Lars Møller
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 7
- COVID-19 Clinical Research Studies 7
- Viral gastroenteritis research and epidemiology 7
- SARS-CoV-2 detection and testing 4
- Epidemiology top 5%
- Substance Abuse Treatment and Outcomes 5
- Obstetrics and Gynecology top 5%
- Modeling and Simulation top 5%
- General Health Professions top 5%
-
- RNA and protein synthesis mechanisms 6
-
- Smoking Behavior and Cessation 5
-
- Virus-based gene therapy research 4
- Co-authors
- Gauden GaleaPeter AndersonBent OttesenHanne Kristine HegaardHanne Wacher KjærgaardPaula AlvesMichael FarrellHeino Stöver
- Partner nations
- DenmarkGermanyFaroe Islands
In The Last Decade
Lars Møller
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 143
- Infectious Diseases 355
- Epidemiology 558
- Obstetrics and Gynecology 102
- Modeling and Simulation 49
- General Health Professions 240
Countries citing papers authored by Lars Møller
This map shows the geographic impact of Lars Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Møller more than expected).
Fields of papers citing papers by Lars Møller
This network shows the impact of papers produced by Lars Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Møller. The network helps show where Lars Møller may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Møller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2022 | 28 | |
| 4 | 2022 | 64 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 21 | |
| 7 | 2021 | 15 | |
| 8 | 2019 | 8 | |
| 9 | 2017 | 10 | |
| 10 | 2014 | 19 | |
| 11 | 2011 | 205 | |
| 12 | 2011 | 54 | |
| 13 | 2010 | 31 | |
| 14 | 2010 | 9 | |
| 15 | 2009 | 11 | |
| 16 | 2008 | 13 | |
| 17 | 2003 | 63 | |
| 18 | 2000 | 52 | |
| 19 | 1998 | 3 | |
| 20 | 1997 | 63 |
About Lars Møller
Lars Møller is a scholar working on Infectious Diseases, Virology and Endocrinology, having authored 56 papers that have together received 1.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (7 papers), Viral gastroenteritis research and epidemiology (7 papers), RNA and protein synthesis mechanisms (6 papers), Smoking Behavior and Cessation (5 papers), Substance Abuse Treatment and Outcomes (5 papers), Virus-based gene therapy research (4 papers) and SARS-CoV-2 detection and testing (4 papers). The work is most often cited by research in Infectious Diseases (355 citations), Epidemiology (558 citations) and Obstetrics and Gynecology (102 citations). Lars Møller has collaborated with scholars based in Denmark, Germany and Faroe Islands. Frequent co-authors include Gauden Galea, Peter Anderson, Bent Ottesen, Hanne Kristine Hegaard, Hanne Wacher Kjærgaard, Paula Alves, Michael Farrell, Heino Stöver, Dagmar Hedrich and Soraya Mayet. Their work appears in journals such as Public Health, Viruses, Emerging infectious diseases, Acta Obstetricia Et Gynecologica Scandinavica and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.